Bioxytran, Inc. (BIXT)
OTCMKTS
· Delayed Price · Currency is USD
0.1260
-0.0229 (-15.40%)
Apr 3, 2025, 3:45 PM EST
Bioxytran Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2017 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2017 - 2018 |
| Cash & Equivalents | 0.03 | 0.03 | 0.3 | 0.07 | 0.04 | 0.17 | Upgrade
|
| Cash & Short-Term Investments | 0.03 | 0.03 | 0.3 | 0.07 | 0.04 | 0.17 | Upgrade
|
| Cash Growth | -56.81% | -91.17% | 308.25% | 73.57% | -75.42% | 365.87% | Upgrade
|
| Other Receivables | - | - | - | - | - | 0.05 | Upgrade
|
| Receivables | - | - | - | - | - | 0.05 | Upgrade
|
| Prepaid Expenses | - | - | - | - | 0.27 | - | Upgrade
|
| Total Current Assets | 0.03 | 0.03 | 0.3 | 0.07 | 0.32 | 0.22 | Upgrade
|
| Other Intangible Assets | - | - | - | - | 0.01 | - | Upgrade
|
| Long-Term Deferred Charges | 0.12 | 0.11 | 0.08 | 0.05 | - | - | Upgrade
|
| Total Assets | 0.16 | 0.14 | 0.37 | 0.12 | 0.33 | 0.22 | Upgrade
|
| Accounts Payable | - | 0 | 0 | - | 0 | 0.01 | Upgrade
|
| Accrued Expenses | 0.26 | 0.3 | 1.46 | 1.16 | 0.35 | 0.06 | Upgrade
|
| Short-Term Debt | 0.93 | 1.93 | 2.17 | 2.12 | 1.61 | 0.85 | Upgrade
|
| Other Current Liabilities | 0.05 | 1.03 | 0.04 | - | 0.31 | 0.1 | Upgrade
|
| Total Current Liabilities | 1.24 | 3.25 | 3.66 | 3.28 | 2.27 | 1.02 | Upgrade
|
| Total Liabilities | 1.24 | 3.25 | 3.66 | 3.28 | 2.27 | 1.02 | Upgrade
|
| Common Stock | 0.08 | 0.15 | 0.12 | 0.11 | 0.1 | 0.09 | Upgrade
|
| Additional Paid-In Capital | 17.21 | 12.92 | 8.39 | 5.88 | 1.8 | 1.36 | Upgrade
|
| Retained Earnings | -18.4 | -15.5 | -11.22 | -8.75 | -4.72 | -2.24 | Upgrade
|
| Total Common Equity | -1.11 | -2.43 | -2.7 | -2.76 | -2.83 | -0.8 | Upgrade
|
| Minority Interest | - | -0.68 | -0.59 | -0.4 | 0.89 | - | Upgrade
|
| Shareholders' Equity | -1.08 | -3.11 | -3.29 | -3.16 | -1.94 | -0.8 | Upgrade
|
| Total Liabilities & Equity | 0.16 | 0.14 | 0.37 | 0.12 | 0.33 | 0.22 | Upgrade
|
| Total Debt | 0.93 | 1.93 | 2.17 | 2.12 | 1.61 | 0.85 | Upgrade
|
| Net Cash (Debt) | -0.9 | -1.9 | -1.87 | -2.05 | -1.57 | -0.68 | Upgrade
|
| Net Cash Per Share | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 | -0.01 | Upgrade
|
| Filing Date Shares Outstanding | 88.13 | 166.49 | 123.5 | 110.84 | 100.75 | 88.03 | Upgrade
|
| Total Common Shares Outstanding | 82.24 | 145.64 | 123.25 | 110.84 | 97.45 | 86.48 | Upgrade
|
| Working Capital | -1.21 | -3.22 | -3.37 | -3.21 | -1.95 | -0.8 | Upgrade
|
| Book Value Per Share | -0.01 | -0.02 | -0.02 | -0.02 | -0.03 | -0.01 | Upgrade
|
| Tangible Book Value | -1.11 | -2.43 | -2.7 | -2.76 | -2.84 | -0.8 | Upgrade
|
| Tangible Book Value Per Share | -0.01 | -0.02 | -0.02 | -0.02 | -0.03 | -0.01 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.